Hydroxychloroquine and risk of development of cancers: a nationwide population-based cohort study
I-Chieh Mao,1 Ching-Yeh Lin,2 Chia-Lin Wu,3,4 Chew-Teng Kor,5,6 Chia-Chu Chang3,7–9 1Division of Critical Care, Department of Internal Medicine, Changhua Christian Hospital, Changhua, Taiwan; 2Division of Hematology and Oncology, Department of Internal Medicine, Changhua Christia...
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2018-08-01
|
Series: | Therapeutics and Clinical Risk Management |
Subjects: | |
Online Access: | https://www.dovepress.com/hydroxychloroquine-and-risk-of-development-of-cancers-a-nationwide-pop-peer-reviewed-article-TCRM |
id |
doaj-c09d1969d8a94de7982fec6d8110da8e |
---|---|
record_format |
Article |
spelling |
doaj-c09d1969d8a94de7982fec6d8110da8e2020-11-25T02:20:51ZengDove Medical PressTherapeutics and Clinical Risk Management1178-203X2018-08-01Volume 141435144339948Hydroxychloroquine and risk of development of cancers: a nationwide population-based cohort studyMao ICLin CYWu CLKor CTChang CCI-Chieh Mao,1 Ching-Yeh Lin,2 Chia-Lin Wu,3,4 Chew-Teng Kor,5,6 Chia-Chu Chang3,7–9 1Division of Critical Care, Department of Internal Medicine, Changhua Christian Hospital, Changhua, Taiwan; 2Division of Hematology and Oncology, Department of Internal Medicine, Changhua Christian Hospital, Changhua, Taiwan; 3Division of Nephrology, Department of Internal Medicine, Changhua Christian Hospital, Changhua, Taiwan; 4Institute of Clinical Medicine, National Yang-Ming University, Taipei, Taiwan; 5Internal Medicine Research Center, Changhua Christian Hospital, Changhua, Taiwan; 6Graduate Institute of Statistics and Information Science, National Changhua University of Education, Changhua, Taiwan; 7Department of Internal Medicine, Kuang Tien General Hospital, Taichung, Taiwan; 8School of Medicine, Chung-Shan Medical University, Taichung, Taiwan; 9Department of Nutrition, Hungkuang University, Taichung, Taiwan Background: Hydroxychloroquine (HCQ), one of the disease-modifying antirheumatic drugs, may lead to an inhibition of autophagy. Autophagy, an intracellular self-defense mechanism for the lysosomal degradation of cytoplasmic components such as damaged organelles, plays a role in protecting against neoplasm growth but is also vital for cancer cells due to an increased intracellular metabolic waste. Methods: Taiwan National Health Insurance Database was subjected to analysis to investigate the effect of HCQ exposure on cancer risk in patients with autoimmune diseases. Cancer incidence between patients with or without at least 12-month HCQ use was compared by propensity score-matched landmark analysis. A total of 100,000 participants were enrolled, including 7,662 patients who were diagnosed with autoimmune diseases between January 1, 2000, and December 31, 2012. Results: After propensity score matching, HCQ user and nonuser groups consist of 1,933 patients with a mean follow-up time of 7.82 and 6.7 years, respectively. During the follow-up period, 93 HCQ users and 77 HCQ nonusers developed cancers. Meanwhile, Kaplan–Meier estimates showed no difference in the overall incidence of cancer between HCQ users and nonusers. Conclusion: This propensity score-matched study of Taiwanese patients with autoimmune diseases suggested that HCQ exposure did not increase the cancer risk. Keywords: hydroxychloroquine, autophagy, cancer, autoimmune diseases, propensity scorehttps://www.dovepress.com/hydroxychloroquine-and-risk-of-development-of-cancers-a-nationwide-pop-peer-reviewed-article-TCRMHydroxychloroquineautophagycancerautoimmune diseasespropensity score. |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Mao IC Lin CY Wu CL Kor CT Chang CC |
spellingShingle |
Mao IC Lin CY Wu CL Kor CT Chang CC Hydroxychloroquine and risk of development of cancers: a nationwide population-based cohort study Therapeutics and Clinical Risk Management Hydroxychloroquine autophagy cancer autoimmune diseases propensity score. |
author_facet |
Mao IC Lin CY Wu CL Kor CT Chang CC |
author_sort |
Mao IC |
title |
Hydroxychloroquine and risk of development of cancers: a nationwide population-based cohort study |
title_short |
Hydroxychloroquine and risk of development of cancers: a nationwide population-based cohort study |
title_full |
Hydroxychloroquine and risk of development of cancers: a nationwide population-based cohort study |
title_fullStr |
Hydroxychloroquine and risk of development of cancers: a nationwide population-based cohort study |
title_full_unstemmed |
Hydroxychloroquine and risk of development of cancers: a nationwide population-based cohort study |
title_sort |
hydroxychloroquine and risk of development of cancers: a nationwide population-based cohort study |
publisher |
Dove Medical Press |
series |
Therapeutics and Clinical Risk Management |
issn |
1178-203X |
publishDate |
2018-08-01 |
description |
I-Chieh Mao,1 Ching-Yeh Lin,2 Chia-Lin Wu,3,4 Chew-Teng Kor,5,6 Chia-Chu Chang3,7–9 1Division of Critical Care, Department of Internal Medicine, Changhua Christian Hospital, Changhua, Taiwan; 2Division of Hematology and Oncology, Department of Internal Medicine, Changhua Christian Hospital, Changhua, Taiwan; 3Division of Nephrology, Department of Internal Medicine, Changhua Christian Hospital, Changhua, Taiwan; 4Institute of Clinical Medicine, National Yang-Ming University, Taipei, Taiwan; 5Internal Medicine Research Center, Changhua Christian Hospital, Changhua, Taiwan; 6Graduate Institute of Statistics and Information Science, National Changhua University of Education, Changhua, Taiwan; 7Department of Internal Medicine, Kuang Tien General Hospital, Taichung, Taiwan; 8School of Medicine, Chung-Shan Medical University, Taichung, Taiwan; 9Department of Nutrition, Hungkuang University, Taichung, Taiwan Background: Hydroxychloroquine (HCQ), one of the disease-modifying antirheumatic drugs, may lead to an inhibition of autophagy. Autophagy, an intracellular self-defense mechanism for the lysosomal degradation of cytoplasmic components such as damaged organelles, plays a role in protecting against neoplasm growth but is also vital for cancer cells due to an increased intracellular metabolic waste. Methods: Taiwan National Health Insurance Database was subjected to analysis to investigate the effect of HCQ exposure on cancer risk in patients with autoimmune diseases. Cancer incidence between patients with or without at least 12-month HCQ use was compared by propensity score-matched landmark analysis. A total of 100,000 participants were enrolled, including 7,662 patients who were diagnosed with autoimmune diseases between January 1, 2000, and December 31, 2012. Results: After propensity score matching, HCQ user and nonuser groups consist of 1,933 patients with a mean follow-up time of 7.82 and 6.7 years, respectively. During the follow-up period, 93 HCQ users and 77 HCQ nonusers developed cancers. Meanwhile, Kaplan–Meier estimates showed no difference in the overall incidence of cancer between HCQ users and nonusers. Conclusion: This propensity score-matched study of Taiwanese patients with autoimmune diseases suggested that HCQ exposure did not increase the cancer risk. Keywords: hydroxychloroquine, autophagy, cancer, autoimmune diseases, propensity score |
topic |
Hydroxychloroquine autophagy cancer autoimmune diseases propensity score. |
url |
https://www.dovepress.com/hydroxychloroquine-and-risk-of-development-of-cancers-a-nationwide-pop-peer-reviewed-article-TCRM |
work_keys_str_mv |
AT maoic hydroxychloroquineandriskofdevelopmentofcancersanationwidepopulationbasedcohortstudy AT lincy hydroxychloroquineandriskofdevelopmentofcancersanationwidepopulationbasedcohortstudy AT wucl hydroxychloroquineandriskofdevelopmentofcancersanationwidepopulationbasedcohortstudy AT korct hydroxychloroquineandriskofdevelopmentofcancersanationwidepopulationbasedcohortstudy AT changcc hydroxychloroquineandriskofdevelopmentofcancersanationwidepopulationbasedcohortstudy |
_version_ |
1715507271516028928 |